MARKER THERAPEUTICS, INC - 8 Year Stock Price History | MRKR

The latest closing stock price for MARKER THERAPEUTICS, INC as of November 08, 2024 is 4.14.

  • An investor who bought $1,000 worth of MARKER THERAPEUTICS, INC stock at the IPO in 2016 would have $-924 today, roughly -1 times their original investment - a -27.58% compound annual growth rate over 8 years.
  • The all-time high MARKER THERAPEUTICS, INC stock closing price was 123.30 on June 18, 2018.
  • The MARKER THERAPEUTICS, INC 52-week high stock price is 6.16, which is 48.8% above the current share price.
  • The MARKER THERAPEUTICS, INC 52-week low stock price is 2.44, which is 41.1% below the current share price.
  • The average MARKER THERAPEUTICS, INC stock price for the last 52 weeks is 4.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

MARKER THERAPEUTICS, INC - 8 Year Stock Price History | MRKR

  • An investor who bought $1,000 worth of MARKER THERAPEUTICS, INC stock at the IPO in 2016 would have $-924 today, roughly -1 times their original investment - a -27.58% compound annual growth rate over 8 years.
  • The all-time high MARKER THERAPEUTICS, INC stock closing price was 123.30 on June 18, 2018.
  • The MARKER THERAPEUTICS, INC 52-week high stock price is 6.16, which is 48.8% above the current share price.
  • The MARKER THERAPEUTICS, INC 52-week low stock price is 2.44, which is 41.1% below the current share price.
  • The average MARKER THERAPEUTICS, INC stock price for the last 52 weeks is 4.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$78.6B
Takeda Pharmaceutical (TAK)$44.1B
Merck (MKKGY)$21.2B
Astellas Pharma (ALPMY)$20.4B
Sandoz Group AG (SDZNY)$19.7B
United Therapeutics (UTHR)$18B
Summit Therapeutics (SMMT)$15.6B
Neurocrine Biosciences (NBIX)$12.6B
Shionogi (SGIOY)$12.5B
Catalent (CTLT)$10.9B
Madrigal Pharmaceuticals (MDGL)$7.7B
Jazz Pharmaceuticals (JAZZ)$7.4B
Orion OYJ (ORINY)$6.8B
Ionis Pharmaceuticals (IONS)$6.1B
Corcept Therapeutics (CORT)$5.7B
Crinetics Pharmaceuticals (CRNX)$4.8B
PTC Therapeutics (PTCT)$3.3B
Dyne Therapeutics (DYN)$2.9B
Catalyst Pharmaceuticals (CPRX)$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.7B
Arrowhead Pharmaceuticals (ARWR)$2.7B
Soleno Therapeutics (SLNO)$2.5B
NewAmsterdam Pharma (NAMS)$2B
Recursion Pharmaceuticals (RXRX)$1.9B
Centessa Pharmaceuticals (CNTA)$1.8B
Harrow (HROW)$1.8B
Ocular Therapeutix (OCUL)$1.7B
Xencor (XNCR)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.6B
ARS Pharmaceuticals (SPRY)$1.6B